Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    AALL0631
Show Display Options
Rank Status Study
1 Active, not recruiting Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Acute Undifferentiated Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia;   Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: vincristine sulfate;   Drug: daunorubicin hydrochloride;   Drug: cyclophosphamide;   Drug: pegaspargase;   Drug: asparaginase;   Drug: prednisone;   Drug: methylprednisolone;   Drug: dexamethasone;   Drug: cytarabine;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Biological: filgrastim;   Drug: leucovorin calcium;   Drug: etoposide;   Drug: mercaptopurine;   Drug: lestaurtinib;   Other: laboratory biomarker analysis;   Other: pharmacological study

Study has passed its completion date and status has not been verified in more than two years.